Actively Recruiting
HYEEG Discourse in Psychosis: A Neurobehavioural Study
Led by Douglas Mental Health University Institute · Updated on 2025-05-18
110
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This multimodal study explores the mechanisms underlying social dysfunction in individuals with schizophrenia. It focuses on the relationship between disorganized communication and social interaction, aiming to identify measurable markers of disorganized communication and link them to clinical symptoms and social functioning. Key Research Questions: How do neural and behavioural synchrony contribute to social impairments in schizophrenia? What roles do interbrain synchrony, motor imitation, reaction time, and verbal coherence play in disorganized communication? Participants will: 1. Engage in structured and semi-structured real-time social interactions while undergoing dual-brain electroencephalogram (EEG) hyperscanning to measure neural and behavioural activity. 2. Perform nonverbal tasks such as motor imitation and reaction time assessments to investigate coordination and behavioural synchrony patterns. 3. Participate in a clinical interview that evaluates verbal production, thought coherence, and speech organization. By combining these assessments, the study aims to advance our understanding of how social and communication impairments manifest in schizophrenia. The findings will contribute to developing improved diagnostic tools and targeted interventions, ultimately supporting patients in achieving better social functioning and quality of life.
CONDITIONS
Official Title
HYEEG Discourse in Psychosis: A Neurobehavioural Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- English or French-speaking participants matched as dyads
- Age between 18 and 60 years
- Diagnosed with schizophrenia or schizoaffective disorder by a psychiatrist according to DSM-5 criteria
- Illness onset less than 5 years ago based on starting antipsychotic treatment
You will not qualify if you...
- Primary diagnosis of alcohol or drug addiction (co-morbid substance abuse with psychotic disorder allowed)
- Severe medical disorder explaining psychotic symptoms
- Past or current primary neurological disorder affecting speech
- IQ below 70 or concurrent pervasive developmental disorder such as autism
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Douglas Mental Health University Institute
Montreal, Quebec, Canada, H4H 1R3
Actively Recruiting
Research Team
E
Emmanuel Olarewaju, PhD Candidate
CONTACT
L
Lena Palaniyappan, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here